Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...
Cardiff Oncology will host a conference call and live webcast at 4:30 p.m. ET/1:30 p.m. PT on 7, 2025. Individuals interested in listening to the live conference call may do so by using the webcast ...
7h
HealthDay on MSNShort-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial CancerShort-course vaginal cuff brachytherapy (VCB) is noninferior to standard regimens for short-term quality of life in ...
The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...
SI-BONE (NASDAQ:SIBN – Get Free Report) and Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two ...
16h
Stocktwits on MSNCandel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders RejoiceShares of Candel Therapeutics Inc. surged nearly 10% on Wednesday and extended gains in after-hours trading following a bullish call from Wall Street. Canaccord initiated coverage on the stock with a ...
Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health Organization’s cancer agency has found.
Several Tri-Valley high school students have been recognized by the Society for Science for their scientific aptitude and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results